Group 1 - Goldman Sachs has assigned a "Buy" rating to Sea (SE.US) with a target price of $193 [1] - For the three months ending in June, Sea's revenue increased by 38% year-over-year to a record $5.26 billion, surpassing analysts' average estimate of $5 billion [1] - Net profit surged from $79.9 million in the same period last year to $414.2 million [1]

Company Performance - Aris Water Solutions reported quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.24 per share, representing an earnings surprise of -20.83% [1] - The company posted revenues of $124.09 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.61%, compared to year-ago revenues of $101.12 million [2] - Over the last four quarters, Aris Water Solutions has surpassed consensus revenue estimates four times, but has only exceeded EPS estimates once [2] Stock Performance - Aris Water Solutions shares have lost about 1.4% since the beginning of the year, while the S&P 500 has gained 8.6% [3] - The current Zacks Rank for Aris Water Solutions is 5 (Strong Sell), indicating expected underperformance in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is $0.28 on revenues of $122.99 million, and for the current fiscal year, it is $1.04 on revenues of $485.6 million [7] - The outlook for the Waste Removal Services industry, where Aris Water Solutions operates, is currently in the bottom 28% of Zacks industries, which may impact stock performance [8]

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on SkyWater Technology, Inc. (SKYT), and emphasizes the importance of validating these recommendations with other indicators like the Zacks Rank [1][5]. Group 1: Brokerage Recommendations - SkyWater Technology has an average brokerage recommendation (ABR) of 1.60, indicating a position between Strong Buy and Buy, with 60% of recommendations being Strong Buy and 20% being Buy [2]. - The article suggests that while the ABR indicates a buying opportunity, investors should not rely solely on this information due to the limited success of brokerage recommendations in predicting stock price increases [5][10]. Group 2: Zacks Rank vs. ABR - The Zacks Rank is presented as a more reliable indicator of a stock's near-term price performance, driven by earnings estimate revisions, and is classified into five groups from Strong Buy to Strong Sell [8][11]. - The Zacks Rank is updated more frequently than the ABR, making it a timely tool for predicting future stock prices, as it reflects changes in earnings estimates quickly [13]. Group 3: SkyWater Technology's Performance - The Zacks Consensus Estimate for SkyWater Technology has remained unchanged at -$0.01 over the past month, suggesting steady analyst views on the company's earnings prospects [14]. - Due to the unchanged consensus estimate and other factors, SkyWater Technology holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [15].

Core Viewpoint - The average brokerage recommendation (ABR) for Sea Limited is 1.52, indicating a consensus leaning towards a "Buy" rating, but caution is advised as brokerage recommendations may not reliably predict stock performance [2][5][10]. Brokerage Recommendations - Sea Limited has an ABR of 1.52, which is between "Strong Buy" and "Buy," based on recommendations from 22 brokerage firms [2]. - Out of the 22 recommendations, 15 are classified as "Strong Buy" (68.2%) and 2 as "Buy" (9.1%) [2]. Limitations of Brokerage Recommendations - Brokerage recommendations often exhibit a positive bias due to the vested interests of the firms, leading to a higher number of "Strong Buy" ratings compared to "Strong Sell" [6][10]. - The ABR may not be up-to-date, and brokerage analysts tend to be overly optimistic, which can mislead investors [10][12]. Zacks Rank Comparison - Zacks Rank is a proprietary tool that categorizes stocks based on earnings estimate revisions, showing a strong correlation with near-term stock price movements [8][11]. - The Zacks Rank for Sea Limited is currently 4 (Sell), indicating a negative outlook based on recent earnings estimate revisions, which have declined by 3.8% to $4.07 [13][14]. Investment Implications - Given the declining earnings estimates and the Zacks Rank of 4, it is advisable to approach the "Buy" recommendation from the ABR with caution [14].

Group 1 - Super Group (SGHC) Limited has an average brokerage recommendation (ABR) of 1.14, indicating a consensus between Strong Buy and Buy, with 85.7% of recommendations being Strong Buy and 14.3% being Buy [2][5] - The reliability of brokerage recommendations is questioned, as studies show limited success in guiding investors towards stocks with the best price increase potential [5][10] - Analysts from brokerage firms tend to exhibit a positive bias in their ratings due to vested interests, leading to a higher number of favorable ratings compared to negative ones [6][10] Group 2 - Zacks Rank is highlighted as a more effective tool for predicting stock price movements, categorizing stocks from Strong Buy to Strong Sell based on earnings estimate revisions [8][11] - The Zacks Rank is updated more frequently than the ABR, reflecting timely changes in analysts' earnings estimates, which correlates strongly with near-term stock price movements [12] - For Super Group (SGHC), the Zacks Consensus Estimate for the current year remains unchanged at $0.47, resulting in a Zacks Rank of 3 (Hold), suggesting caution despite the favorable ABR [13][14]

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on MicroStrategy (MSTR), and highlights the disparity between brokerage ratings and actual stock performance, suggesting that investors should be cautious in relying solely on these recommendations [1][5][10]. Brokerage Recommendations for MicroStrategy - MicroStrategy has an average brokerage recommendation (ABR) of 1.38, indicating a consensus between Strong Buy and Buy, based on recommendations from 13 brokerage firms [2][4]. - Out of the 13 recommendations, 11 are classified as Strong Buy and one as Buy, which together account for 84.6% and 7.7% of all recommendations respectively [2]. Limitations of Brokerage Recommendations - Studies indicate that brokerage recommendations have limited success in guiding investors towards stocks with the highest price increase potential [5]. - Analysts from brokerage firms often exhibit a positive bias in their ratings due to vested interests, leading to a disproportionate number of Strong Buy recommendations compared to Strong Sell [6][10]. Zacks Rank as an Alternative - The Zacks Rank, a proprietary stock rating tool, categorizes stocks from Strong Buy to Strong Sell and is based on earnings estimate revisions, which are more reliable indicators of near-term stock performance [8][11]. - The Zacks Rank is updated more frequently than the ABR, making it a timely tool for predicting future stock prices [12]. Current Earnings Estimates for MicroStrategy - The Zacks Consensus Estimate for MicroStrategy has declined by 627.3% over the past month to -$15.73, reflecting analysts' growing pessimism regarding the company's earnings prospects [13]. - This significant decline in earnings estimates has resulted in a Zacks Rank of 4 (Sell) for MicroStrategy, suggesting caution despite the favorable ABR [14].

分组1 - Stem, Inc. reported a quarterly loss of $3.73 per share, which was worse than the Zacks Consensus Estimate of a loss of $3, representing an earnings surprise of -24.33% [1] - The company posted revenues of $38.37 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 15.93%, and showing an increase from $34 million in the same quarter last year [2] - Over the last four quarters, Stem has surpassed consensus EPS estimates two times and topped revenue estimates three times [2] 分组2 - The stock has underperformed the market, losing about 3.4% since the beginning of the year, while the S&P 500 gained 7.9% [3] - The current consensus EPS estimate for the coming quarter is -$2.00 on revenues of $36.3 million, and for the current fiscal year, it is -$10.20 on revenues of $145.2 million [7] - The Computers - IT Services industry, to which Stem belongs, is currently in the bottom 40% of the Zacks industry rankings, indicating potential challenges ahead [8]

Company Performance - Vermilion Energy reported a quarterly loss of $0.2 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.06, representing an earnings surprise of -233.33% [1] - The company posted revenues of $320.77 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 26.71%, and down from $350.04 million a year ago [2] - Over the last four quarters, Vermilion has not surpassed consensus EPS estimates and has topped revenue estimates only once [2] Stock Movement and Outlook - Vermilion shares have declined approximately 16.4% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] - The company's earnings outlook is crucial for understanding future stock performance, with current consensus EPS estimates at $0.07 for the coming quarter and $0.29 for the current fiscal year [4][7] Industry Context - The Oil and Gas - Exploration and Production - International industry, to which Vermilion belongs, is currently ranked in the bottom 18% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Vermilion's stock performance [5]

Group 1 - Relay Therapeutics reported a quarterly loss of $0.41 per share, better than the Zacks Consensus Estimate of a loss of $0.49, and an improvement from a loss of $0.69 per share a year ago, resulting in an earnings surprise of +16.33% [1] - The company achieved revenues of $0.68 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 35.40%, compared to zero revenues a year ago [2] - Relay Therapeutics shares have declined approximately 14.3% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] Group 2 - The earnings outlook for Relay Therapeutics is mixed, with the current consensus EPS estimate for the coming quarter at -$0.45 on $0.5 million in revenues, and -$1.86 on $19.09 million in revenues for the current fiscal year [7] - The Zacks Industry Rank indicates that the Medical - Drugs sector is currently in the top 35% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8]

分组1 - TripAdvisor reported quarterly earnings of $0.46 per share, exceeding the Zacks Consensus Estimate of $0.42 per share, and up from $0.39 per share a year ago, representing an earnings surprise of +9.52% [1] - The company posted revenues of $529 million for the quarter ended June 2025, which was slightly below the Zacks Consensus Estimate by 0.27%, but an increase from $497 million year-over-year [2] - TripAdvisor has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has gained approximately 11.6% since the beginning of the year, outperforming the S&P 500's gain of 7.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.62 on revenues of $572.28 million, and for the current fiscal year, it is $1.45 on revenues of $1.94 billion [7] - The Zacks Industry Rank indicates that the Internet - Commerce sector is currently in the bottom 34% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]